A Pilot Study in Severe Patients With Takayasu Arteritis.

Abroad (travel likely)RecruitingPHASE4

Conditions

Takayasu Arteritis · Tocilizumab · Adalimumab · Treatment

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of Rheumatology in Zhongshan hospital, Fudan University, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Lindi Jiang, PhD) · zsh-rheum@hotmail.com · +86-021-64041990

Study leads

Lindi Jiang, PhD
Study Chair
Fudan University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis

Takayasu Arteritis

Abroad (travel likely)RecruitingPHASE4

Shanghai, China

Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission

Takayasu Arteritis

Abroad (travel likely)Recruiting

Istanbul, Turkey (Türkiye)

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Rheumatoid Arthritis (RA) · Juvenile Idiopathic Arthritis (JIA) · Systemic Lupus Erythematosus (SLE)

Abroad (travel likely)RecruitingPHASE4

São Paulo, Brazil · São Paulo, Brazil

Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis

Takayasu Arteritis

Abroad (travel likely)RecruitingPHASE4

Shanghai, China